Research & Development

Innovative ideas lead to trend-setting technologies.

Venture Capital

Evonik also obtains access to innovative technologies and new business options through its corporate venture capital activities. 

We invest specifically in specialized technology funds and start-ups of strategic relevance to Evonik. In this
way, we gain insights into innovative developments at a very early stage. We have made more than 24 investments since 2012. In addition to investments to strengthen the Sustainable Nutrition growth field, in 2018 Evonik invested, among others, in Velox Puredigital Ltd, Rosh Ha’Ayin (Israel). Velox has new digital printing technology that allows top-quality printing of metal, plastic, or glass packaging, either in extremely small series or on an industrial scale.

Evonik Venture Capital: New investments in 2017



Technology/business model

Strategic focus on the following
Evonik competencies


Düsseldorf (Germany)

NUMAFERM, a biotechnology company, is working on more efficient production of peptides.

Peptides and their applications are of enormous interest for our Specialty Additives and Health & Care growth engines.

Digital Growth Fund I 

Munich (Germany)

This fund provides capital for fast-growing young IndustrialTech and FinTech companies with proven and successful B2B business models.

Our investment in Digital Growth Fund I is a strong partnership that strengthens Evonik in an important field of the future: digitalization.



If you have any question, please mail to